Visfatin, which regulates glucose homeostasis through nicotinamide adenine dinucleotide biosynthesis and exhibits insulin-like effects, may be considered a response to regulate blood glucose levels with its increased levels in obesity. This evidence concerns the gene INS and obesity disorder.